Stock GLMD GALMED PHARMACEUTICALS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Galmed Pharmaceuticals Ltd.

Equities

GLMD

IL0011313900

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-05-13 pm EDT 		5-day change 1st Jan Change
0.3883 USD -2.51% Intraday chart for Galmed Pharmaceuticals Ltd. -7.37% -14.66%
Apr. 04 Galmed Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 15 Galmed Pharmaceuticals Ltd. Announces Grant of New Patent for the Combination of Aramchol with Resmetirom (MGL-3196, REZDIFFRA) for the Treatment of Nash and Liver Fibrosis CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
GALMED PHARMACEUTICALS LTD. Stock Galmed Pharmaceuticals Ltd.
 2.33M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 111B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 105B
ARGENX SE Stock argenx SE
 21.93B -
BIONTECH SE Stock BioNTech SE
 22.34B -
GENMAB A/S Stock Genmab A/S
 18.59B
  1. Stock Market
  2. Equities
  3. GLMD Stock
  4. Charts Galmed Pharmaceuticals Ltd.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW